Evidence map›Paper›PMID 25852127›Full record

ArticleJournal of lipid research2015

Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Monika Sharma, Anne Von Zychlinski-Kleffmann, Carolyn M Porteous, Gregory T Jones, Michael J A Williams, Sally P A McCormick

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-InflammatoryOxidative medicine and cellular longevity · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Monika SharmaDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Anne Von Zychlinski-KleffmannDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Carolyn M PorteousDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Gregory T JonesDepartments of Surgical Sciences University of Otago, Dunedin, New Zealand.
Michael J A WilliamsMedicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Sally P A McCormickDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated levels of lipoprotein (a) [Lp(a)] are a well-established risk factor for developing CVD. While Lp(a) levels are thought to be independent of other plasma lipoproteins, some trials have reported a positive association between Lp(a) and HDL. Whether Lp(a) has a direct effect on HDL is not known. Here we investigated to determine whether Lp(a) had any effect on the ABCA1 pathway of HDL production in liver cells. Incubation of HepG2 cells with Lp(a) upregulated the PPARγ protein by 1.7-fold and the liver X receptor α protein by 3-fold. This was accompanied by a 1.8-fold increase in ABCA1 protein and a 1.5-fold increase in cholesterol efflux onto apoA1. We showed that Lp(a) was internalized by HepG2 cells, however, the ABCA1 response to Lp(a) was mediated by the selective uptake of oxidized phospholipids (oxPLs) from Lp(a) via the scavenger receptor-B1 and not by Lp(a) internalization per se. We conclude that there is a biological connection between Lp(a) and HDL through the ability of Lp(a)'s oxPLs to upregulate HDL biosynthesis.

Indexed as

ATP Binding Cassette Transporter 1CD36 AntigensHepatocytesHep G2 CellsHumansLipoprotein(a)Oxidation-ReductionPhospholipidsProtein TransportUp-RegulationATP Binding Cassette Transporter 1CD36 AntigensLipoprotein(a)Phospholipidsadenosine 5′-triphosphate binding cassette transporter A1cholesterol effluxhigh density lipoproteinnuclear receptor/liver X receptornuclear receptor/peroxisome proliferator-activated receptor

Identifiers

PMID25852127
PMCPMC4479336
OpenAlexW2035026191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.